ADIAL PHARMACEUTICALS, INC.
Profile
Company Names
ADIAL PHARMACEUTICALS, INC.
ADIAL PHARMACEUTICALS, L.L.C.
Addresses
4870 SADLER ROAD, SUITE 300, GLEN ALLEN, VA 23060
4870 SADLER ROAD, SUITE 300, GLEN ALLEN, VA 23060
1180 SEMINOLE TRAIL SUITE 495, CHARLOTTESVILLE, VA 22902
1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA 22901
1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA 22901
204 E. HIGH STREET, CHARLOTTESVILLE, VA 22902
1001 RESEARCH PARK BLVD., SUITE 100, CHARLOTTESVILLE, VA 22911
Phone Numbers
(804) 487-8196
434-422-9800
(434) 422-9800
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2010
State Incorporated:
VIRGINIA
Total Amount Raised:
$38,288,152.00
Number of Funding Rounds:
19
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
19
2025-11-28
$4,285,289.00
$4,285,289.00
$0.00
18
2025-05-02
$4,815,379.00
$4,815,379.00
$0.00
17
2024-03-06
$287,500.00
$287,500.00
$0.00
Equity
16
2023-10-19
$3,998,582.00
$3,998,582.00
$0.00
Equity
15
2023-05-31
$52,500.00
$3,052,500.00
$3,000,000.00
Equity
14
2023-02-23
$61,603.00
$61,603.00
$0.00
13
2022-02-11
$10,000,000.00
$10,000,000.00
$0.00
12
2021-07-06
$500,004.00
$5,000,000.00
$4,499,996.00
Equity
11
2021-03-11
$291,003.00
$2,100,003.00
$1,809,000.00
Equity
10
2020-11-18
$295,750.00
$15,295,750.00
$15,000,000.00
Equity
9
2020-09-21
$500,000.00
$500,000.00
$0.00
Equity
8
2020-06-09
$5,217,000.00
$5,217,000.00
$0.00
Equity
7
2018-06-03
$325,000.00
$325,000.00
$0.00
Debt
6
2018-02-23
$500,000.00
$500,000.00
$0.00
Debt
5
2017-11-21
$100,000.00
$100,000.00
$0.00
Debt
4
2017-06-11
$40,000.00
$40,000.00
$0.00
Equity
3
2017-05-01
$287,500.00
$287,500.00
$0.00
Debt
2
2013-06-30
$2,631,042.00
$3,000,000.00
$368,958.00
Equity
1
2011-03-11
$4,100,000.00
$4,100,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CARY
CLAIBORNE
EXECUTIVE OFFICER, DIRECTOR
CARY
J.
CLAIBORNE
EXECUTIVE OFFICER, DIRECTOR
TONY
GOODMAN
DIRECTOR, EXECUTIVE OFFICER
BANKOLE
A.
JOHNSON
EXECUTIVE OFFICER, DIRECTOR
VINAY
SHAH
EXECUTIVE OFFICER
WILLIAM
B.
STILLEY, III
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-03-06
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-10-19
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-05-31
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-07-06
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-03-11
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-11-18
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-09-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-06-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2018-06-03
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2018-02-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-11-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-06-11
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-05-01

